CellAxia
About:
CellAxia is a biotechnology firm that research, develops, and markets pharmaceuticals and regenerative medicine products.
Website: https://www.cellaxia.co.jp/
Top Investors: Mitsubishi UFJ Capital, Mizuho Capital, Miyako Capital, Kyogin Lease & Capital, Okasan Capital Partners
Description:
CellAxia is a biotechnology startup that creates medications for cell treatment. Drug discovery bio-venture aiming at the practical application of advanced research such as cell therapy. It serves clients operating in the healthcare sector.
Total Funding Amount:
720M JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Tokyo, Tokyo, Japan
Founded Date:
2017-01-01
Contact Email:
info(AT)cellaxia.co.jp
Founders:
Makoto Seki
Number of Employees:
11-50
Last Funding Date:
2020-09-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai